Award
Delivery Order #SPE2DR26FF4MN
Short-Term Delivery Order for HAVRIX Vaccine Syringes Awarded to AmerisourceBergen
Buyer
Defense Logistics Agency
Award Amount
$200.14
Ceiling
$200.14
Awarded
March 04, 2026
Period of Performance
Mar 04, 2026 – Mar 05, 2026
Identifier
SPE2DR26FF4MN
NAICS
424210
This award is a delivery order contract issued under an existing indefinite delivery vehicle (IDV) agreement to AmerisourceBergen Drug Corp, a prominent pharmaceutical sourcing and distribution company. The contract involves the procurement of a specific pharmaceutical product: HAVRIX vaccine syringes, sized at 0.5 ml. AmerisourceBergen is responsible for supplying these vaccine units to support healthcare providers' immunization needs. This short-term, defined delivery highlights the ongoing importance of maintaining timely supply chain operations for essential pharmaceutical products. The scope covers the delivery of these vaccine syringes within a narrow performance window, ensuring rapid fulfillment for public health purposes. This award is part of a larger, multi-year pharmaceutical procurement vehicle that continuously supports federal healthcare programs. The order was likely competitively sourced under the umbrella agreement to streamline access to critical medicines without additional solicitation. The contract's place of performance is Conshohocken, Pennsylvania, consistent with AmerisourceBergen's distribution facilities. This targeted delivery order reinforces the significance of strategic pharmaceutical logistics in supporting public health vaccination efforts.
Description
4571034093!HAVRIX 720 UNIT/0.5 ML SYRINGE 0.5ML